NewEdge Advisors’s Alto Ingredients ALTO Stock Holding History

NewEdge Advisors’s Portfolio ALTO Stock Details ALTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-70,813	Closed	-$204K	–	4134
2025 Q4	$204K	Buy	+70,813	New	+$134K	﹤0.01%	2575
2024 Q2	–	Sell	-1	Closed	-$2	–	3790
2024 Q1	$2	Hold	1	–	–	﹤0.01%	3802
2023 Q4	$3	Hold	1	–	–	﹤0.01%	3728
2023 Q3	$4	Buy	+1	New	+$4	﹤0.01%	3447

Other funds holding ALTO

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

NewEdge Advisors's ALTO Position: Q1 2026 in Review

NewEdge Advisors sold out of Alto Ingredients (ALTO) in Q1 2026, closing a stake of 70,813 shares — an estimated $204K sold.

NewEdge Advisors first reported a position in ALTO in Q3 2023 and held it in 4 quarters. The position peaked at $204K in Q4 2025. 102 funds tracked by Wall St. Rank hold ALTO as of Q1 2026.

NewEdge Advisors reported no remaining Alto Ingredients position as of Q1 2026 after selling out during the quarter.
NewEdge Advisors sold 70,813 Alto Ingredients shares in Q1 2026, an estimated $204K.
NewEdge Advisors first reported a position in Alto Ingredients in Q3 2023 and held it in 4 quarters.
NewEdge Advisors's Alto Ingredients position peaked at $204K in Q4 2025.
102 funds tracked by Wall St. Rank held Alto Ingredients as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.